Intuitive Surgical Inc (ISRG)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $151.74B
Last updated: Nov 17, 2026 at 4:43 PM ET
Intuitive Surgical Inc (ISRG) Statistics
Intuitive Surgical (ISRG) has a market cap of $151.74B and an enterprise value of $149.46B. Revenue grew 20.45% over the last 12 months from the 12 months before. Its return on invested capital of 17.82% compares with a 7.46% median across 9 similar companies.
Total Valuation
Enterprise value is 1.50% below the market cap, as cash exceeds debt.
| Market Cap | $151.74B |
|---|---|
| Enterprise Value | $149.46B |
| Latest price (Nov 17, 2026) | $430.53 |
Key Dates
The next earnings report is expected on Jan 20, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 20, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 20, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 13.0x and 9.4x. Its year-end P/E ranged from 28.4x to 80.7x from 2016 to 2025.
| P/E Ratio | 39.8x |
|---|---|
| Forward P/E | 37.5x |
| P/S Ratio | 13.0x |
| Forward P/S | 12.7x |
| P/B Ratio | 9.4x |
| P/TBV Ratio | 10.6x |
| P/FCF Ratio | 41.8x |
| P/OCF Ratio | 37.1x |
| PEG Ratio | 2.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 33.5x EBITDA and 41.1x free cash flow.
| EV / Earnings | 50.3x |
|---|---|
| EV / Sales | 12.9x |
| EV / EBITDA | 33.5x |
| EV / EBIT | 41.3x |
| EV / FCF | 41.1x |
Price Statistics
The stock is down 21.65% over 52 weeks and trades 2.36% above its 50-day average.
| Beta (1Y) | 0.92 |
|---|---|
| 52-Week Change | -21.65% |
| 1-Month Change | -0.61% |
| 3-Month Change | +8.25% |
| 6-Month Change | -2.50% |
| 5-Year Change | +19.63% |
| 10-Year Change | +478.52% |
| Total Return (1Y) | -21.65% |
| Total Return (3Y CAGR) | +12.14% |
| Total Return (5Y CAGR) | +3.69% |
| Return vs SPY (1Y) | -32.82% |
| Max Drawdown (1Y) | -44.00% |
| Max Drawdown (3Y) | -45.61% |
| Sharpe Ratio (1Y) | -0.67 |
| Correlation with SPY (1Y) | 0.35 |
| 50-Day Average | $420.62 |
| 200-Day Average | $428.72 |
| 52-Week Range | $328.57 to $603.88 |
| RSI (14 Days) | 46.4 |
| Average Volume (20 Days) | 2.65M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.33x current liabilities, and total debt is 0.04x shareholder equity.
| Current Ratio | 3.33x |
|---|---|
| Quick Ratio | 2.49x |
| Debt / Equity | 0.04x |
| Debt / EBITDA | 0.16x |
| Debt / FCF | 0.19x |
Returns and Efficiency
Return on invested capital is 17.82% over the last 12 months, against a 5-year average of 15.69%.
| Return on Equity (ROE) | 18.60% |
|---|---|
| Return on Assets (ROA) | 15.37% |
| Return on Invested Capital (ROIC) | 17.82% |
| Return on Capital Employed (ROCE) | 21.52% |
| ROE (5Y Average) | 14.14% |
| ROA (5Y Average) | 12.28% |
| ROIC (5Y Average) | 15.69% |
| Asset Turnover | 0.60x |
| Inventory Turnover | 1.83x |
| Receivables Turnover | 6.82x |
| Cash Conversion Cycle | 226 days |
Taxes
Income tax took 17.85% of pretax income over the last 12 months.
| Income Tax (TTM) | $645.90M |
|---|---|
| Effective Tax Rate | 17.85% |
Scores
ISRG has an Altman Z-Score of 29.81, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 29.81 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $11.58B over the last 12 months.
| Revenue | $11.58B |
|---|---|
| Revenue Growth (YoY) | +20.45% |
| Gross Profit | $7.78B |
| Operating Income | $3.28B |
| Pretax Income | $3.62B |
| Net Income | $2.97B |
| EBITDA | $4.41B |
| EBIT | $3.62B |
| Reported EPS (TTM) | $10.83 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 82.64% of the $19.35B in total assets.
| Cash and Equivalents | $2.98B |
|---|---|
| Total Debt | $698.30M |
| Net Cash | $2.28B |
| Net Cash Per Share | $6.53 |
| Working Capital | $5.90B |
| Shareholder Equity | $15.99B |
| Book Value Per Share | $45.81 |
| Tangible Book Value | $14.22B |
| Tangible Book Per Share | $40.74 |
| Total Assets | $19.35B |
| Total Liabilities | $3.23B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $491.50M of capital spending, operating cash flow left $3.60B of free cash flow.
| Operating Cash Flow | $4.09B |
|---|---|
| Capital Expenditures | $491.50M |
| Free Cash Flow | $3.60B |
| FCF Per Share | $10.18 |
| Depreciation and Amortization | $794.50M |
| Share Repurchases | $4.62B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 28.37%, against a 5-year average of 27.89%.
| Gross Margin | 67.19% |
|---|---|
| Operating Margin | 28.37% |
| Pretax Margin | 31.26% |
| Net Margin | 25.68% |
| EBITDA Margin | 38.12% |
| EBIT Margin | 31.26% |
| FCF Margin | 31.08% |
| Gross Margin (5Y Average) | 67.32% |
| Operating Margin (5Y Average) | 27.89% |
| Net Margin (5Y Average) | 26.79% |
Growth
Revenue grew 17.39% a year over 3 years, and EPS 23.94% a year.
| Revenue Growth (3Y CAGR) | +17.39% |
|---|---|
| Revenue Growth (5Y CAGR) | +18.22% |
| EPS Growth (3Y CAGR) | +23.94% |
| EPS Growth (5Y CAGR) | +21.45% |
| FCF Growth (3Y CAGR) | +37.49% |
| FCF Growth (5Y CAGR) | +16.85% |
| Operating Income Growth (3Y CAGR) | +23.15% |
| Book Value Per Share Growth (2Y CAGR) | +15.38% |
| Tangible Book Per Share Growth (2Y CAGR) | +15.73% |
Dividends and Yields
ISRG does not pay a dividend. Its free cash flow yield is 2.39%.
| Earnings Yield | 2.51% |
|---|---|
| FCF Yield | 2.39% |
| Buyback Yield | 2.83% |
| Shareholder Yield | 2.83% |
Stock Splits
The last split was a 3-for-1 forward split on Oct 5, 2021.
| Last Split Date | Oct 5, 2021 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:1 |
Peer Position
Against 10 similar companies, ISRG has the highest P/E.
P/E RatioPeer median 19.3x
P/S RatioPeer median 2.7x
ROICPeer median 7.46%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.05%
| P/E Ratio | 39.8x vs 19.3x median |
|---|---|
| P/S Ratio | 13.0x vs 2.7x median |
| ROIC | 17.82% vs 7.46% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +20.45% vs +9.05% median |
Analyst Forecast
Consensus estimates put revenue growth at 15.17% and EPS growth at 18.16% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +15.17% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +18.16% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ISRG
What is ISRG's market cap?
Intuitive Surgical has a market cap of $151.74B. Its enterprise value, which adds debt and subtracts cash, is $149.46B.
What is ISRG's P/E ratio?
Intuitive Surgical has a trailing P/E ratio of 39.8x and a forward P/E of 37.5x.
How many shares of ISRG are outstanding?
Intuitive Surgical has 349.00M shares outstanding. The count is down 2.13% from a year earlier.
Does ISRG pay a dividend?
No. Intuitive Surgical does not pay a dividend.
How much debt does ISRG have?
Intuitive Surgical has $698.30M of total debt and $2.98B of cash and equivalents, a net cash position of $2.28B.
ISRG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts